What's happening at HerelleX?
Milestones, scientific progress and company updates.
3 notes
CompanyHerelleX joins LAB+ at Institut Pasteur de Montevideo
It is Uruguay's first company builder specializing in life sciences.
CompanyHerelleX recognized at Santander X Global Awards, MWC 2026
Our CEO, Agustín Pablo Seijo, shares the vision behind FluoTB, the low-cost tuberculosis diagnostic tool we are developing.
CompanyVideo: Agustín Seijo presents FluoTB at the Santander X Global Awards
Our CEO, Agustín Pablo Seijo, shares the vision behind FluoTB, the low-cost tuberculosis diagnostic tool we are developing.
Get involved
Bring FluoTB to where it's needed.
The potential market is ~200,000 tests a year in Argentina and over 30 million a year across high-incidence countries — a global TB-diagnostics market projected to grow from USD 2.28B in 2024 to USD 3.18B by 2030. If accessible diagnosis is your mission too, let's talk.
Simplified view
One sample. One test, adjusted to routine lab workflows.
A respiratory sample is processed with standard lab methods, incubated with our reagents, then fixed for safe fluorescence reading — even up to 10 days later.
01.
Decontamination
Competing flora is cleared.
02.
Infect and express
Sample meets phage reagents.
03.
Fixation
Fixed — safe to handle and store.